PuSH - Publikationsserver des Helmholtz Zentrums München: Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: Analysis of a large multicenter study.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Wang, L.* ; Heckman, M.G.* ; Aasly, J.O.* ; Annesi, G.* ; Bozi, M.* ; Chung, S.J.* ; Clarke, C.* ; Crosiers, D.* ; Eckstein, G.N. ; Garraux, G.* ; Hadjigeorgiou, G.M.* ; Hattori, N.* ; Jeon, B.* ; Kim, Y.J.* ; Kubo, M.* ; Lesage, S.* ; Lin, J.J.* ; Lynch, T.* ; Lichtner, P. ; Mellick, G.D.* ; Mok, V.* ; Morrison, K.E.* ; Quattrone, A.* ; Satake, W.* ; Silburn, P.A.* ; Stefanis, L.* ; Stockton, J.D.* ; Tan, E.K.* ; Toda, T.* ; Brice, A.* ; van Broeckhoven, C.* ; Uitti, R.J.* ; Wirdefeldt, K.* ; Wszolek, Z.* ; Xiromerisiou, G.* ; Maraganore, D.M.* ; Gasser, T.* ; Kruger, R.* ; Farrer, M.J.* ; Ross, O.A.* ; Sharma, M.*

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: Analysis of a large multicenter study.

Neurobiol. Aging 49, 217.e1-217.e4 (2017)

Postprint

Forschungsdaten

DOI

PMC

	Open Access Green

Abstract
Metriken
Zusatzinfos

A recent study MacLeod et al. has shown that an interaction between variants at the LRRK2 and PARK16 loci influences risk of development of Parkinson's disease (PD). Our study examines the proposed interaction between LRRK2 and PARK16 variants in modifying PD risk using a large multicenter series of PD patients (7715) and controls (8261) from sites participating in the Genetic Epidemiology of Parkinson's Disease Consortium. Our data does not support a strong direct interaction between LRRK2 and PARK16 variants; however, given the role of retromer and lysosomal pathways in PD, further studies are warranted.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

5.117

1.203